Chronic lymphocytic leukemia (CLL), begins in the bone marrow and is the most common type of leukemia in adults. Abramson Cancer Center has a full suite of diagnostic tools and treatment options to help you.
Chronic lymphocytic leukemia (CLL) is a type of blood cancer that begins in the bone marrow. CLL is the most common type of leukemia in adults. There are almost 16,000 people diagnosed with CLL each year.
Treatment for chronic lymphocytic leukemia is in the midst of a revolutionary transformation. Clinicians and cancer researchers have embarked on a new era in the management of CLL with the development and approval of potent and effective targeted therapies. These therapies are tailored to individuals based on the bio-markers or specific characteristics of their disease.
Chronic lymphocytic leukemia can be treated at the Abramson Cancer Center by our Leukemia Program.
Every step of cancer treatment, from a cancer diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.
Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex health care situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.